However, although lower total levels of immunoreactivity were detected in the AD subject than in the WE case (p = 0.0221), it is noteworthy to highlight that a striking IκB-α labeling was observed in the astrocytes (Figures 4Fe,f), which was also found in the WE case with less intensity, with some astrocytes reacting in the same way to this marker (Figures 4Ed). This evidence concerns the gene NFKBIA and Alzheimer disease.